FDA Investigator Marie K Kinkade

Marie K Kinkade has conducted inspections on 113 sites in 1 countries as of 01 Nov 2011. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
113
Last Inspection Date:
01 Nov 2011
Investigator Role:
FDA Investigator
Redica ID:
100003965
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Marie K Kinkade:
Adam S Freeman, Alexandria L Capuano, Alla Dubrovsky, Althea A Williams, Amanda N Schaupp, Andrea A Branche, Andrea George, PhD, Andrew P Lin, Angel K Sandhu, Anh M Lac, Anthony E Keller, RPh, Arindam Dasgupta, PhD, Ashar P Parikh, Ashley A Mutawakkil, Barbara J Wilcox, PhD, Calvin B Koerner, Capri R Woolridge, Carl Lee, Carole L Jones, CDR Rochelle B Young, RPh, MSA, Christine M Parmentier, Christopher R Czajka, Cindy W Lewis, Claudia Mperez Kasmarski, Cynthia J Tsui, Cynthia L Evitt, Daniel J Roberts, Darlene B Almogela, Diane Cvan Leeuwen, Dolores Harper, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Dustin P Tran, Dustin R Abaonza, Edward D Harris, Elizabeth A Dakan, Emily Shacter, Eric L Dong, BS, Eric W Anderson, Francis J Eng, Frank P Bianco, Gerald Feldman, Gerald M Feldman, PhD, Henry K Lau, Humberto Z Gomez, James C Yee, James R Evans, Jane M Kreis, Jeanne Fringer, PhD, Jeffrey M Watson, Jeffrey W Shrifter, DPM, Jennifer L Degroot, Jennifer L Johnson, Joan T Briones, Jocelyn T Ramos, Joey V Quitania, John A Gonzalez, Joseph A Seitz, III, Joseph Kutze, PhD, Joseph P Iser, MD, Joshua S Hunt, Juan A Morales, Jude C Dikes, Juliane Kjung Lau, Karla J Gibler, Katlin N Stubbs, Keren Arkin, Kevin P Foley, Kim Lthomas Cruse, Kristin M Abaonza, Lakisha M Williams, Lance Mde Souza, MBA, Laurie P Norwood, Laverne Puckett, Lawton W Lum, LCDR Jennifer H Rhyu, Linda Linh N Adams, Linda S Shook, Linh Tu, Lori J Silverstein, Lydia S Chan, Mabel M Lee, Maida Henesian (NMI), Mariza M Jafary, Mark E Chan, Marsha W Major, Marshalette O Edwards, Mary Ewilkerson Brinsko, Michael Shanks, MS, Michael T Cyrus, Michelle Rfrazier Jessen, PhD, Mihaly S Ligmond, Min Shanmabel Liu, Monique C Lo, Navneet Kaur, Nayan J Patel, Nicholas L Hunt, Nicholas Obiri, PhD, Omotunde O Osunsanmi, Paul E Stein, Paul M Kawamoto, Peter E Baker, Peter Kessler, PhD, Phung, Quynh H Strandberg, Randall F Albright, Raymond T Oji, Rebecca Rodriguez, Rebecca T Davis, Riley C Myers, PhD, Robert D Tollefsen, Sandra S Saniga, Scott N Lim, Serge L Beaucage, Sergio Chavez (NMI), Sharon K Thoma, PharmD, Sheilyn H Huang, Shelley H Beausoleil, Sheri S Oliver, Sherri J Jackson, Sidney B Priesmeyer, Stephanie A Slater, MS, Steve P Yost, Steven J Branch, Steven R Gillenwater, Stuart W Russell, Thea C Grome, Thomas W Gordon, Thuy T Nguyen, LCDR, Timothy C Grome, Travelle D Mason, Truong Xuan Nguyen (Andy), Victoria Taylor, Walden H Lee, William V Millar, Yi Wang, PhD

Marie K Kinkade's Documents

Publish Date Document Type Title
August, 2003 FDA 483 Health Sciences Consulting Corp - Form 483, 2003-08-14
July, 2003 FDA 483 San Joaquin Comm Hosp Irb - Form 483, 2003-07-31
August, 2003 EIR Health Sciences Consulting Corp - EIR, 2003-08-14
May, 2008 FDA 483 Kristen N. Ganjoo, M.D. - Form 483, 2008-05-08
December, 2003 FDA 483 Stanislaus Surgical Hospital IRB - Form 483, 2003-12-23
September, 2003 FDA 483 Response Valley Children's Healthcare IRB - Form 483R, 2003-10-03
September, 2003 EIR Valley Children's Healthcare IRB - EIR, 2003-09-26
December, 2003 EIR Stanislaus Surgical Hospital IRB - EIR, 2003-12-23
June, 2006 EIR Genentech, Inc. - EIR, 2006-06-26
July, 2001 EIR Rowbotham, Michael C., M.D. - EIR, 2001-07-13
January, 2000 FDA 483 ASEGUA THERAPEUTICS LLC - Form 483, 2000-01-05
October, 2004 EIR Robert A. Greene, MD - EIR, 2004-10-26
September, 2003 FDA 483 Valley Children's Healthcare IRB - Form 483, 2003-09-26
July, 2003 EIR San Joaquin Comm Hosp Irb - EIR, 2003-07-31
February, 2001 EIR Astex Pharmaceuticals, Inc - EIR, 2001-02-16
February, 2000 EIR Rubin, Daniel L., M.D. - EIR, 2000-02-24

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more